Concepedia

Kristy M. Ainslie

KM

Statistics

Publications

80

Citations

4K

H-Index

37

Active since

2002

Affiliations

University of North Carolina at Chapel Hill(Current)

The Ohio State University

North Carolina State University

University of Georgia

Pennsylvania State University

Kristy M. Ainslie is an author at University of North Carolina at Chapel Hill specializing in drug delivery, immunology, and pharmacy.

ORCID

Publications per year

2002–2025

80

Publications

80

Heparan Sulfate Proteoglycan Is a Mechanosensor on Endothelial Cells

Jeffry Florian, Jason R. Kosky, Kristy M. Ainslie et al. · Circulation Research · 2003 · 610 citations

, , +14

A nanoparticle-incorporated STING activator enhances antitumor immunity in PD-L1–insensitive models of triple-negative breast cancer

Ning Cheng, Rebekah Watkins-Schulz, Robert D. Junkins et al. · JCI Insight · 2018 · 252 citations · Full text

, , +17

A robust microparticle platform for a STING-targeted adjuvant that enhances both humoral and cellular immunity during vaccination

Robert D. Junkins, Matthew D. Gallovic, Brandon M. Johnson et al. · Journal of Controlled Release · 2017 · 151 citations

, , +16

In Vitro Analysis of Acetalated Dextran Microparticles as a Potent Delivery Platform for Vaccine Adjuvants

Eric M. Bachelder, Tristan T. Beaudette, Kyle E. Broaders et al. · Molecular Pharmaceutics · 2010 · 129 citations

, , +17

Synthesis and Characterization of Acetalated Dextran Polymer and Microparticles with Ethanol as a Degradation Product

Kevin Kauffman, Clement Do, Sadhana Sharma et al. · ACS Applied Materials & Interfaces · 2012 · 104 citations · Full text

, , +15

1–5 of 80